ReviewPost-infectious group A streptococcal autoimmune syndromes and the heart
Introduction
Human infections with Streptococcus pyogenes (group A streptococcus, GAS) constitute a major, worldwide health problem, with up to 700 million cases annually [1]. GAS is an anaerobic, Gram-positive coccus and its only known reservoir is in humans. The oropharynx and skin are the primary colonization sites for GAS and around 12% of apparently normal individuals harbour GAS as a commensal organism in these locations [2].
GAS has a long history with human disease. Intriguingly, it can cause both infectious and post-infectious, immune-mediated diseases. The former includes non-invasive infections, such as pharyngitis and impetigo; invasive infections, such as pneumonia, septic arthritis and necrotising fasciitis; and toxin-mediated syndromes, such as toxic shock syndrome and scarlet fever. Immune syndromes following GAS infection include acute rheumatic fever (ARF), rheumatic heart disease (RHD), post-streptococcal glomerulonephritis (PSGN) and possibly, paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) (Fig. 1). This review focuses on the clinical and pathological features of these sterile, post-infectious GAS syndromes in order to gain insight into host immunopathogenic mechanisms and hopefully, to suggest new approaches to diagnosis and treatment.
Section snippets
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD)
ARF occurs at a median of two weeks after an antecedent GAS infection. The diagnosis is based on the Jones criteria, comprising major and minor manifestations. The five major manifestations in the Jones criteria reflect target tissue involvement: synovium (inflammatory arthritis), heart valves (endocarditis), brain (chorea), skin (erythema marginatum) and subcutaneous tissue (nodules). A diagnosis of ARF is made in the presence of two major, or one major and two minor, manifestations, together
Genetics of host susceptibility to post-streptococcal immune syndromes
Only a few studies have explored genetic susceptibility to PSGN and PANDAS. Increased frequencies of HLA-DRW4 [48] and HLA-DRB1*0311 [49] were reported in Venezuelan and Egyptian cohorts with PSGN compared to healthy controls. In a Turkish study, children with homozygote ‘a’ alleles, or heterozygote ‘a’/‘b’ alleles, of the endothelial nitric oxide synthase gene intron 4a/b (eNOS4a/b) variable number of tandem repeats polymorphism, had a greater risk for PSGN than those carrying homozygote ‘b’
Bacterial factors that contribute to post-streptococcal immune syndromes
At a molecular level, GAS can be typed by sequencing the hypervariable N-terminal regions of the emm gene encoding the M protein, the major cell surface glycoprotein of GAS. GAS strains can now be classified into 223 emm-types [115]. A number of studies have attempted to link GAS strains or emm-types to disease patterns. Particular emm-types are commonly associated with pharyngitis in high-income countries [116] and also appear to be responsible for invasive disease and ARF in the same
Complement and immune complex activation
PSGN is considered an immune complex disorder, during which streptococcal proteins and anti-GAS antibodies deposit in renal glomeruli, either as pre-formed immune complexes or forming in situ. Immune complex deposition leads to classical pathway complement activation, triggering inflammatory cell recruitment and tissue damage [160], [161]. Two GAS antigens have been implicated as initiators of PGSN-NAPlr, a streptococcal form of glyceraldehyde 3-phosphate dehydrogenase, and SpeB, a cysteine
Where to next in understanding post-streptococcal immune syndromes?
Surprisingly, there are currently no definitive laboratory-based tests for the various post-streptococcal clinical syndromes and diagnosis remains largely clinical. As outlined above, traditional immunological approaches have yielded limited results. A way forward may lie in the application of the new “omics” technologies – genomics, transcriptomics, proteomics, and metabolomics – to these ancient syndromes. Omics approaches provide an unprecedented breadth of information on disease states due
Immunopathogenesis of post-streptococcal immune syndromes: shared or specific mechanisms?
The clinically distinctive post-streptococcal immune syndromes may result from preferential activation of different components of the immune response, acting within distinct anatomical compartments of hosts with variable genetic and environmentally determined risk. PSGN is caused by glomerular deposition of immune complexes, complement activation and temporary amplification of the actions of plasmin. PSGN appears to be a ‘one hit’ immune complex disorder that typically resolves without
Take-home messages
- •
In susceptible hosts, GAS engages immune pathways that result in post-infectious sequelae, affecting various organs in distinctive ways.
- •
Genetic risk factors play a role in post-GAS sequelae, but the mechanisms involved remain poorly understood.
- •
Molecular mimicry between GAS M protein and host cardiac myosin is the most widely accepted cause of ARF and RHD, but additional mechanisms involving a range of alpha coiled-coil endogenous molecules, or other cross reactive targets are likely.
- •
Immune
Acknowledgements
Supported by the Reid Charitable Trusts, the National Health and Medical Research Council of Australia (grants 1023407 and 1016647 to Dr. Wicks and grant 0123462 to Dr. Inouye and Prof. Carapetis), and the Victorian State Government (Operational Infrastructure Grant). Many thanks to the key support of Prof. Doug Hilton of the Walter and Eliza Hall Institute of Medical Research.
References (293)
- et al.
Acute rheumatic fever
Lancet
(2005) - et al.
Diagnostic criteria of acute rheumatic fever
Autoimmun Rev
(2014) - et al.
The global burden of group A streptococcal diseases
Lancet Infect Dis
(2005) - et al.
Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial
J Pediatr
(2003) - et al.
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Lancet
(2012) - et al.
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Lancet
(2012) Glomerulonephritis
Lancet
(1999)- et al.
Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life
Kidney Int
(2012) - et al.
PANDAS: a commentary
J Psychosom Res
(2003) - et al.
Relationship of movements and behaviors to Group A Streptococcus infections in elementary school children
Biol Psychiatry
(2007)
Evaluation of autoimmune phenomena in patients with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)
Autoimmun Rev
Therapeutic plasma exchange and intravenous immunoglobulin for obsessive–compulsive disorder and tic disorders in childhood
Lancet
A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections
Biol Psychiatry
Family studies of the HLA system in acute post-streptococcal glomerulonephritis
Hum Immunol
Psychiatric disorders in first-degree relatives of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS)
J Am Acad Child Adolesc Psychiatry
Autoimmune diseases: solution of the environmental, immunological and genetic components with principles for immunotherapy and transplantation
Autoimmun Rev
HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors
Am Heart J
Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease
J Autoimmun
Association of HLA DRB1-DQA1-DQB1 haplotypes with rheumatic heart disease in Taiwan
Int J Cardiol
HLA class II antigens in rheumatic fever. Analysis of the DR locus by restriction fragment-length polymorphism and oligotyping
Hum Immunol
DNA typing of HLA class II genes in Japanese patients with rheumatic heart disease
J Mol Cell Cardiol
The association between mannose-binding lectin gene polymorphism and rheumatic heart disease
Hum Immunol
A study on the association of TNF-alpha(-308), IL-6(-174), IL-10(-1082) and IL-1Ra(VNTR) gene polymorphisms with rheumatic heart disease in Pakistani patients
Cytokine
Interleukin-1 receptor antagonist gene (IL1RN) polymorphism possibly associated to severity of rheumatic carditis in a Brazilian cohort
Cytokine
Association of MASP2 polymorphisms and protein levels with rheumatic fever and rheumatic heart disease
Hum Immunol
Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever
Mol Immunol
TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production
J Autoimmun
Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis
Pediatrics
Guidelines for the diagnosis of rheumatic fever. Jones criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association
JAMA
The Australian guideline for prevention, diagnosis and management of acute rheumatic heart disease
Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever
Arch Dis Child
Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population?
Epidemiol Infect
Rheumatic fever and rheumatic heart disease: a report of a WHO Expert Consultation
The natural history of rheumatic fever and rheumatic heart disease in the Orient
Jpn Heart J
AHA guidelines on prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis
Am Fam Physician
Rheumatic fever in indigenous Australian children
J Paediatr Child Health
Preventing recurrent rheumatic fever: the role of register based programmes
Heart
Prevention and treatment of rheumatic heart disease in the developing world
Nat Rev Cardiol
Prevalence of rheumatic heart disease detected by echocardiographic screening
N Engl J Med
Evaluation of a screening protocol using auscultation and portable echocardiography to detect asymptomatic rheumatic heart disease in Tongan schoolchildren
Nat Clin Pract Cardiovasc Med
Rheumatic fever in children younger than 5 years: is the presentation different?
Pediatrics
Pathogenic mechanism of acute post-streptococcal glomerulonephritis
Scand J Infect Dis
Post-streptococcal glomerulonephritis in Sydney: a 16-year retrospective review
J Paediatr Child Health
Post-streptococcal glomerulonephritis following pyoderma
Rev Infect Dis
An epidemic of acute post-streptococcal glomerulonephritis among aboriginal children
J Paediatr Child Health
Outbreak of acute post streptococcal glomerulonephritis in the Northern Territory — 2000
NT Dis Control Bull.
Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature
Am J Trop Med Hyg
Post-streptococcal glomerulo-nephritis: histopathologic and clinical studies of the acute, subsiding acute and early chronic latent phases
J Clin Invest
Complement profiles in acute post-streptococcal glomerulonephritis
Pediatr Nephrol
Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases
Am J Psychiatry
Cited by (86)
Rheumatic cardiopathies and its risk factors: about 50 cases
2024, Annales de Cardiologie et d'AngeiologieRheumatic Heart Disease: JACC Focus Seminar 2/4
2023, Journal of the American College of CardiologyA fatal case of fulminant group: a streptococcal infection in a neonate
2023, Egyptian Journal of Forensic Sciences